The Antigenicity of the Tumor Cell - Context Matters.
From the Department of Clinical Molecular Biology (EpiGen), Medical Division, Akershus University Hospital, Lørenskog, and the Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo - both in Norway.
Vessela N
VN
Kristensen
D000951:Antigens, Neoplasm / Q000276:immunology*; D001782:Blood Donors; D018984:Epitopes, T-Lymphocyte / Q000235:genetics / Q000276:immunology; D006801:Humans; D007167:Immunotherapy; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology; D008545:Melanoma / Q000235:genetics / Q000276:immunology* / Q000628:therapy; D009154:Mutation; D009369:Neoplasms / Q000276:immunology*; D012333:RNA, Messenger; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology
D000951:Antigens, Neoplasm; D018984:Epitopes, T-Lymphocyte; D012333:RNA, Messenger; D011948:Receptors, Antigen, T-Cell